CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 240 enrolled
Drug / intervention
Propranolol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03348683
NCT03348683Phase 2Completed
CompareCT.gov

Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients: a Double-blind Randomized Controlled Trial

Icahn School of Medicine at Mount Sinai·interventional·Posted Nov 21, 2017·Updated Jan 7, 2020

In Brief

A Phase 2 clinical trial evaluating Propranolol and Placebo for Induction of Labor Affected Fetus / Newborn. Completed, enrolled 240 participants across 1 site.

Detailed Summary

A randomized, prospective trial will be offered to women admitted to the labor floors at Mount Sinai Medical Center for labor induction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInduction of Labor Affected Fetus / Newborn
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedNov 21, 2017
Enrollment StartDec 11, 2017
Primary CompletionDec 11, 2018
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 8.6 years ago

Interventions

Propranololdrug

After induction is started with Foley or misoprostol placement, 30 minutes will pass before administration of the one-time study medication, IV Propanolol.

Placebodrug

After induction is started with Foley or misoprostol placement, 30 minutes will pass before administration of IV Saline